PHS
AMRN

PFM Health Sciences’s Amarin Corp AMRN Stock Holding History

PFM Health Sciences’s Portfolio AMRN Stock Details AMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-26,671
Closed -$11.4M – 63
2019
Q4 		$11.4M Buy
+26,671
New +$10.1M 0.54% 44

Other funds holding AMRN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

PFM Health Sciences's AMRN Position: Q1 2020 in Review

PFM Health Sciences sold out of Amarin Corp (AMRN) in Q1 2020, closing a stake of 26,671 shares — an estimated $11.4M sold.

PFM Health Sciences first reported a position in AMRN in Q4 2019 and held it in 1 quarter. The position peaked at $11.4M in Q4 2019. 306 funds tracked by Wall St. Rank hold AMRN as of Q1 2020.

  • PFM Health Sciences reported no remaining Amarin Corp position as of Q1 2020 after selling out during the quarter.
  • PFM Health Sciences sold 26,671 Amarin Corp shares in Q1 2020, an estimated $11.4M.
  • PFM Health Sciences first reported a position in Amarin Corp in Q4 2019 and held it in 1 quarter.
  • PFM Health Sciences's Amarin Corp position peaked at $11.4M in Q4 2019.
  • 306 funds tracked by Wall St. Rank held Amarin Corp as of Q1 2020.

Based on PFM Health Sciences's 13F filing for Q1 2020, filed 15 May 2020.